Lux Capital is a venture capital firm founded by Peter Hebert, Robert Paull, and Josh Wolfe in 2000 . The firm, based in New York with an office in Menlo Park, invests in emerging technologies in the physical and life sciences.
Lux Capital is a venture firm based in New York City and Silicon Valley investing in counter-conventional, seed and early stage science and technology ventures. The firm manages $700 million in assets across four funds. Lux founded strategic holdings in media, research and policy as proprietary sources of intelligence, access and influence – ensuring that portfolio companies are better connected, have deeper insight, and command industry leadership faster than their competition.The Lux Capital team has built more than 20 companies from scratch.
In April 2011, former McKinsey Senior Partner Richard N. Foster and former CIA Director James Woolsey joined Lux Capital as venture partners. In August 2012, former Pfizer Chairman and CEO Jeff Kindler joined Lux Capital as a venture partner.
Currently their team members include General Partner Adam Kalish, Partners Shahin Farshchi, Adam Goulburn, Renata Quintini, Zack Schildhorn, and Bilal Zuberi, Scientist and Residence Samuel Arbesman, Principal Zavain Dar, and Senior Analyst Alex Nguyen.
- BrightSky Labs
- CloudMedx Inc
- Cerulean Pharma [NASDAQ:CERU]
- Crystal IS
- CyPhy Works
- Everspin Technologies
- Genocea Biosciences [NASDAQ:GNCA]
- Halo Neuroscience
- Kala Pharmaceuticals
- Orbital Insight
- Planet Labs
- Nervana Systems
- Scaled Inference
- Siluria Technologies